Like and comment please 

China Cancer Drugmaker Surges 28% in Hong Kong Trading Debut

Hutchmed (China) Ltd., a cancer drug developer backed by billionaire Li Ka-shing, jumped in its firs
China Cancer Drugmaker Surges 28% in Hong Kong Trading Debut

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment3

  • Top
  • Latest
  • 超群yibo
    ·2021-06-30
    Nice
    Reply
    Report
  • Ck38
    ·2021-06-30
    Please like and comment
    Reply
    Report
    Fold Replies
    • Huathk
      Gd
      2021-06-30
      Reply
      Report